Krystal Biotech buy Bank of America Co.
Start price
22.07.25
/
50%
€129.30
Target price
22.07.26
€164.24
Performance (%)
66.74%
Price
29.12.25
€215.60
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Krystal Biotech has seen massive gains of 66.74%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 1.602% | 1.602% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target lowered by analysts at Bank of America Corporation from $193.00 to $192.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€159.10
17.10.25
17.10.25
€217.90
17.10.26
17.10.26
35.51%
29.12.25
29.12.25
